retatrutide release date FDA Approval Status: July 2026 Update Retatrutide, an experimental weight-loss drug,

But this was no pill

Zepbound has a unique mechanism, which involves mimicking two hormones, GLP-1 and GIP, which sets it apart from other weight loss medications

Safety is unknown

Discuss with your healthcare provider before starting any weight loss programme, supplement, or medication whilst breastfeeding

Substance use disorders like alcohol and opioid addiction are closely linked to the brains dopamine reward system, which reinforces behaviours that produce pleasure

Employers can also require documentation of failed attempts at weight loss through lifestyle modification, participation in medically supervised weight management programs, or trial of less expensive weight loss medications before approving GLP-1 coverage